Ignite Creation Date:
2024-05-05 @ 10:16 PM
Last Modification Date:
2024-10-26 @ 10:17 AM
Study NCT ID:
NCT01079741
Status:
COMPLETED
Last Update Posted:
2018-02-13
First Post:
2010-03-02
Brief Title:
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients
Sponsor:
Nina Bhardwaj
Organization:
Icahn School of Medicine at Mount Sinai
Organization Data
Organization:
Icahn School of Medicine at Mount Sinai
Class:
OTHER
Study ID:
GCO 13-1391
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nina Bhardwaj
Lead Sponsor Class:
OTHER
Responsible Party:
Nina Bhardwaj
Responsible Party Title:
Director Tumor Vaccine Program
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Icahn School of Medicine at Mount Sinai
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ludwig Institute for Cancer Research | OTHER |
| Oncovir Inc | INDUSTRY |
| Cancer Research Institute New York City | OTHER |